These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 37633929)

  • 21. Mass spectrometry in clinical proteomics - from the present to the future.
    Palmblad M; Tiss A; Cramer R
    Proteomics Clin Appl; 2009 Jan; 3(1):6-17. PubMed ID: 21136932
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Perspective on Proteomic and Glycomic Biomarkers for Diagnosis, Prognosis, and Prediction of Pancreatic Cancer.
    Hanna-Sawires RG; Schiphuis JH; Wuhrer M; Vasen HFA; van Leerdam ME; Bonsing BA; Mesker WE; van der Burgt YEM; Tollenaar RAEM
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800786
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Methods and applications of single-cell proteomics analysis based on mass spectrometry].
    Qin S; Bai Y; Liu H
    Se Pu; 2021 Feb; 39(2):142-151. PubMed ID: 34227347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The Implementation of Mass Spectrometry-Based Proteomics Workflows in Clinical Routines of Acute Myeloid Leukemia: Applicability and Perspectives.
    Hernandez-Valladares M; Bruserud Ø; Selheim F
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957646
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulatory context and validation of assays for clinical mass spectrometry proteomics (cMSP) methods.
    Hirtz C; Bros P; Brede C; Lescuyer P; Maceski AM; Vialaret J; Delatour V; Lehmann S;
    Crit Rev Clin Lab Sci; 2018 Aug; 55(5):346-358. PubMed ID: 29792094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Advances in high-throughput proteomic analysis].
    Wu Q; Sui X; Tian R
    Se Pu; 2021 Feb; 39(2):112-117. PubMed ID: 34227342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Application and Perspectives of MALDI-TOF Mass Spectrometry in Clinical Microbiology Laboratories.
    Torres-Sangiao E; Leal Rodriguez C; García-Riestra C
    Microorganisms; 2021 Jul; 9(7):. PubMed ID: 34361974
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Advances in chiral separation and analysis by capillary electrophoresis-mass spectrometry].
    Chi Z; Yang L
    Se Pu; 2022 Jun; 40(6):509-519. PubMed ID: 35616196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microfluidic-Mass Spectrometry Interfaces for Translational Proteomics.
    Pedde RD; Li H; Borchers CH; Akbari M
    Trends Biotechnol; 2017 Oct; 35(10):954-970. PubMed ID: 28755975
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative mass spectrometry-based assay development and validation: from small molecules to proteins.
    Božović A; Kulasingam V
    Clin Biochem; 2013 Apr; 46(6):444-55. PubMed ID: 23041077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical perspectives of high-resolution mass spectrometry-based proteomics in neuroscience: exemplified in amyotrophic lateral sclerosis biomarker discovery research.
    Ekegren T; Hanrieder J; Bergquist J
    J Mass Spectrom; 2008 May; 43(5):559-71. PubMed ID: 18416436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Label-free mass spectrometry-based proteomics for biomarker discovery and validation.
    Pham TV; Piersma SR; Oudgenoeg G; Jimenez CR
    Expert Rev Mol Diagn; 2012 May; 12(4):343-59. PubMed ID: 22616700
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease.
    Smith JG; Gerszten RE
    Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mass spectrometry-based clinical proteomics.
    Pusch W; Flocco MT; Leung SM; Thiele H; Kostrzewa M
    Pharmacogenomics; 2003 Jul; 4(4):463-76. PubMed ID: 12831324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preparation and Immunoaffinity Depletion of Fresh Frozen Tissue Homogenates for Mass Spectrometry-Based Proteomics in the Context of Drug Target/Biomarker Discovery.
    Prieto DA; Chan KC; Johann DJ; Ye X; Whitely G; Blonder J
    Methods Mol Biol; 2017; 1647():71-90. PubMed ID: 28808996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology.
    Tsuchida S; Umemura H; Nakayama T
    Molecules; 2020 Oct; 25(20):. PubMed ID: 33080897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Advances in Higher Order Multiplexing Techniques in Proteomics.
    Aggarwal S; Talukdar NC; Yadav AK
    J Proteome Res; 2019 Jun; 18(6):2360-2369. PubMed ID: 31074990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent progress in capillary electrophoresis-based high-sensitivity proteomics].
    Yang Y; Tian R
    Se Pu; 2020 Oct; 38(10):1125-1132. PubMed ID: 34213109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proteomic applications in pathology and laboratory medicine: Present state and future prospects.
    Holmes DT; Romney MG; Angel P; DeMarco ML
    Clin Biochem; 2020 Aug; 82():12-20. PubMed ID: 32442429
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mass Spectrometry Techniques in Emerging Pathogens Studies: COVID-19 Perspectives.
    Mahmud I; Garrett TJ
    J Am Soc Mass Spectrom; 2020 Oct; 31(10):2013-2024. PubMed ID: 32880453
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.